Viral load in patients infected with pandemic H1N1 2009 influenza A virus
- PMID: 19950247
- PMCID: PMC7167040
- DOI: 10.1002/jmv.21664
Viral load in patients infected with pandemic H1N1 2009 influenza A virus
Abstract
Viral shedding profile of infections caused by the pandemic H1N1 2009 influenza A virus has not been reported. The aim of this study was to determine the viral load in different body sites. Viral loads of pandemic H1N1 virus in respiratory specimens, stool, urine, and serum were determined by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Respiratory specimens from patients with seasonal influenza were used as historical controls. Initial pre-treatment viral load were compared between these two groups. Serial respiratory specimens from patients with pandemic H1N1 virus infection were obtained for analysis of viral dynamics. Twenty-two pandemic H1N1 cases and 44 seasonal influenza historical controls were included. The mean initial viral load before oseltamivir therapy was 1.84 x 10(8) copies/ml for pandemic H1N1 virus compared with 3.28 x 10(8) copies/ml in seasonal influenza historical controls (P = 0.085). Among patients with pandemic H1N1 virus infection, peak viral load occurred on the day of onset of symptoms, and declined gradually afterwards, with no virus being detectable in respiratory specimens by RT-PCR 8 days and by culture 5 days after the onset of symptoms respectively, except in one patient. Pandemic H1N1 virus was detected in stool and in urine from 4/9 and 1/14 patients, respectively. Viral culture was also positive from the stool sample with the highest viral load. Younger age was associated with prolonged shedding in the respiratory tract and higher viral load in the stool. Data from this quantitative analysis of viral shedding may have implications for formulating infection control measures.
(c) 2009 Wiley-Liss, Inc.
References
-
- Boivin G, Coulombe Z, Wat C. 2003. Quantification of the influenza virus load by real‐time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir. J Infect Dis 188: 578–580. - PubMed
-
- Buchy P, Mardy S, Vong S, Toyoda T, Aubin JT, Miller M, Touch S, Sovann L, Dufourcq JB, Richner B, Tu PV, Tien NT, Lim W, Peiris JS, Van der Werf S. 2007. Influenza A/H5N1 virus infection in humans in Cambodia. J Clin Virol 39: 164–168. - PubMed
-
- Centers for Disease Control and Prevention . 2009. Serum cross‐reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 58: 521–524. - PubMed
-
- Chan KH, Peiris JSM, Lim W, Nicholls JM, Chiu SS. 2008a. Comparison of nasopharyngeal flocked swabs and aspirates from pediatric patients for rapid diagnosis of respiratory viruses. J Clin Virol 42: 65–69. - PubMed
-
- Chan KH, Yam WC, Pang CM, Chan KM, Lam SY, Lo KF, Poon LL, Peiris JS. 2008b. Comparison of the NucliSens easyMAG and Qiagen BioRobot 9604 nucleic acid extraction systems for detection of RNA and DNA respiratory viruses in nasopharyngeal aspirate samples. J Clin Microbiol 46: 2195–2199. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical